Specifically, IBD was found to be negatively correlated with the expression level of IL-17A, while IL-17B was negatively correlated with IBD, and NAFLD was negatively correlated with the expression level of IL-17F. Here, IL17F is linked to metabolic dysfunction-associated steatotic liver disease.